BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 29464486)

  • 21. Differential Regulation of Neurotrophic Factors During Pathogenic Tau-Aggregation in a Tau Transgenic Mouse Model for Alzheimer's Disease: A Protocol for Double-Labeling mRNA by In Situ Hybridization and Protein Epitopes by Immunohistochemistry.
    Schindowski K
    Methods Mol Biol; 2024; 2754():361-385. PubMed ID: 38512677
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of Cdk5/p25 and tau phosphorylation following chronic brain hypoperfusion in rats involves microRNA-195 down-regulation.
    Sun LH; Ban T; Liu CD; Chen QX; Wang X; Yan ML; Hu XL; Su XL; Bao YN; Sun LL; Zhao LJ; Pei SC; Jiang XM; Zong DK; Ai J
    J Neurochem; 2015 Sep; 134(6):1139-51. PubMed ID: 26118667
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Expression of microRNA-34a in Alzheimer's disease brain targets genes linked to synaptic plasticity, energy metabolism, and resting state network activity.
    Sarkar S; Jun S; Rellick S; Quintana DD; Cavendish JZ; Simpkins JW
    Brain Res; 2016 Sep; 1646():139-151. PubMed ID: 27235866
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-125b induces tau hyperphosphorylation and cognitive deficits in Alzheimer's disease.
    Banzhaf-Strathmann J; Benito E; May S; Arzberger T; Tahirovic S; Kretzschmar H; Fischer A; Edbauer D
    EMBO J; 2014 Aug; 33(15):1667-80. PubMed ID: 25001178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Brain-derived neurotrophic factor protects against tau-related neurodegeneration of Alzheimer's disease.
    Jiao SS; Shen LL; Zhu C; Bu XL; Liu YH; Liu CH; Yao XQ; Zhang LL; Zhou HD; Walker DG; Tan J; Götz J; Zhou XF; Wang YJ
    Transl Psychiatry; 2016 Oct; 6(10):e907. PubMed ID: 27701410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-200c suppression increases tau hyperphosphorylation by targeting 14-3-3γ in early stage of 5xFAD mouse model of Alzheimer's disease.
    Park H; Lee YB; Chang KA
    Int J Biol Sci; 2022; 18(5):2220-2234. PubMed ID: 35342350
    [No Abstract]   [Full Text] [Related]  

  • 27. NMDA receptor dysfunction contributes to impaired brain-derived neurotrophic factor-induced facilitation of hippocampal synaptic transmission in a Tau transgenic model.
    Burnouf S; Martire A; Derisbourg M; Laurent C; Belarbi K; Leboucher A; Fernandez-Gomez FJ; Troquier L; Eddarkaoui S; Grosjean ME; Demeyer D; Muhr-Tailleux A; Buisson A; Sergeant N; Hamdane M; Humez S; Popoli P; Buée L; Blum D
    Aging Cell; 2013 Feb; 12(1):11-23. PubMed ID: 23082852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. microRNAs expression correlates with levels of APP, DYRK1A, hyperphosphorylated Tau and BDNF in the hippocampus of a mouse model for Down syndrome during ageing.
    Chaves JCS; Machado FT; Almeida MF; Bacovsky TB; Ferrari MFR
    Neurosci Lett; 2020 Jan; 714():134541. PubMed ID: 31605772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression.
    Kawashima H; Numakawa T; Kumamaru E; Adachi N; Mizuno H; Ninomiya M; Kunugi H; Hashido K
    Neuroscience; 2010 Feb; 165(4):1301-11. PubMed ID: 19958814
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MiR-26b, upregulated in Alzheimer's disease, activates cell cycle entry, tau-phosphorylation, and apoptosis in postmitotic neurons.
    Absalon S; Kochanek DM; Raghavan V; Krichevsky AM
    J Neurosci; 2013 Sep; 33(37):14645-59. PubMed ID: 24027266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using ΔK280 Tau
    Weng ZK; Lin TH; Chang KH; Chiu YJ; Lin CH; Tseng PH; Sun YC; Lin W; Lee-Chen GJ; Chen CM
    Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-132 aggravates epileptiform discharges via suppression of BDNF/TrkB signaling in cultured hippocampal neurons.
    Xiang L; Ren Y; Cai H; Zhao W; Song Y
    Brain Res; 2015 Oct; 1622():484-95. PubMed ID: 26168887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased pro-nerve growth factor and decreased brain-derived neurotrophic factor in non-Alzheimer's disease tauopathies.
    Belrose JC; Masoudi R; Michalski B; Fahnestock M
    Neurobiol Aging; 2014 Apr; 35(4):926-33. PubMed ID: 24112788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NPY modulates miR-30a-5p and BDNF in opposite direction in an in vitro model of Alzheimer disease: a possible role in neuroprotection?
    Croce N; Gelfo F; Ciotti MT; Federici G; Caltagirone C; Bernardini S; Angelucci F
    Mol Cell Biochem; 2013 Apr; 376(1-2):189-95. PubMed ID: 23358924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Brain derived neurotrophic factor (BDNF) expression is regulated by microRNAs miR-26a and miR-26b allele-specific binding.
    Caputo V; Sinibaldi L; Fiorentino A; Parisi C; Catalanotto C; Pasini A; Cogoni C; Pizzuti A
    PLoS One; 2011; 6(12):e28656. PubMed ID: 22194877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Brain-Derived Neurotrophic Factor Signaling in the Pathophysiology of Alzheimer's Disease: Beneficial Effects of Flavonoids for Neuroprotection.
    Numakawa T; Odaka H
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-922 promotes tau phosphorylation by downregulating ubiquitin carboxy-terminal hydrolase L1 (UCHL1) expression in the pathogenesis of Alzheimer's disease.
    Zhao ZB; Wu L; Xiong R; Wang LL; Zhang B; Wang C; Li H; Liang L; Chen SD
    Neuroscience; 2014 Sep; 275():232-7. PubMed ID: 24950120
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-153 promotes brain-derived neurotrophic factor and hippocampal neuron proliferation to alleviate autism symptoms through inhibition of JAK-STAT pathway by LEPR.
    You YH; Qin ZQ; Zhang HL; Yuan ZH; Yu X
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 30975733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-138 promotes tau phosphorylation by targeting retinoic acid receptor alpha.
    Wang X; Tan L; Lu Y; Peng J; Zhu Y; Zhang Y; Sun Z
    FEBS Lett; 2015 Mar; 589(6):726-9. PubMed ID: 25680531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tau downregulates BDNF expression in animal and cellular models of Alzheimer's disease.
    Rosa E; Mahendram S; Ke YD; Ittner LM; Ginsberg SD; Fahnestock M
    Neurobiol Aging; 2016 Dec; 48():135-142. PubMed ID: 27676333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.